Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2008 3
2009 2
2010 2
2011 1
2018 2
2019 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction.
Gąsior P, Gierlotka M, Szczurek-Katanski K, Osuch M, Roleder M, Hawranek M, Gasior M, Wojakowski W, Polonski L. Gąsior P, et al. Among authors: osuch m. Postepy Kardiol Interwencyjnej. 2018;14(4):347-355. doi: 10.5114/aic.2018.79194. Epub 2018 Nov 9. Postepy Kardiol Interwencyjnej. 2018. PMID: 30603024 Free PMC article.
Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.
Gasior P, Gierlotka M, Szczurek-Katanski K, Osuch M, Gnot R, Hawranek M, Gasior M, Polonski L. Gasior P, et al. Among authors: osuch m. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E362-E368. doi: 10.1002/ccd.27919. Epub 2018 Oct 8. Catheter Cardiovasc Interv. 2019. PMID: 30298545
Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Szkodzinski J, Hudzik B, Osuch M, Romanowski W, Szygula-Jurkiewicz B, Polonski L, Zubelewicz-Szkodzinska B. Szkodzinski J, et al. Among authors: osuch m. Heart Vessels. 2011 Jul;26(4):399-407. doi: 10.1007/s00380-010-0076-2. Epub 2010 Dec 3. Heart Vessels. 2011. PMID: 21127885
Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension.
Lekston A, Chudek J, Gasior M, Wilczek K, Wiecek A, Kokot F, Gierlotka M, Niklewski T, Fijałkowski M, Szyguła-Jurkiewicz B, Wojnicz R, Białas B, Osuch M, Maciejewski B, Poloński L. Lekston A, et al. Among authors: osuch m. Kidney Blood Press Res. 2008;31(5):291-8. doi: 10.1159/000153249. Epub 2008 Sep 5. Kidney Blood Press Res. 2008. PMID: 18772602 Clinical Trial.
Effects of short- and long-term efficacy of percutaneous transluminal renal angioplasty with or without intravascular brachytherapy on regression of left ventricular hypertrophy in patients with renovascular hypertension.
Lekston A, Niklewski T, Gasior M, Chudek J, Wilczek K, Wiecek A, Kokot F, Fijałkowski M, Gierlotka M, Osuch M, Maciejewski B, Poloński L. Lekston A, et al. Among authors: osuch m. Pol Arch Med Wewn. 2009 Apr;119(4):211-8. Pol Arch Med Wewn. 2009. PMID: 19413179 Free article. Clinical Trial.
Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: the effect on blood pressure in patients with renovascular hypertension.
Lekston A, Chudek J, Wilczek K, Gasior M, Wiecek A, Kokot F, Fijałkowski M, Gierlotka M, Szyguła-Jurkiewicz B, Wojnicz R, Białas B, Osuch M, Maciejewski B, Poloński L. Lekston A, et al. Among authors: osuch m. Cardiol J. 2009;16(6):514-20. Cardiol J. 2009. PMID: 19950087 Free article. Clinical Trial.
13 results